Chengdu Easton Biopharmaceuticals Co., Ltd.

Shanghai Stock Exchange 688513.SS

Chengdu Easton Biopharmaceuticals Co., Ltd. Share Price on January 14, 2025: USD 4.12

Chengdu Easton Biopharmaceuticals Co., Ltd. Share Price is USD 4.12 on January 14, 2025, a -23.02% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Chengdu Easton Biopharmaceuticals Co., Ltd. 52-week high Share Price is USD 5.99 on October 08, 2024, which is 45.51% above the current Share Price.
Chengdu Easton Biopharmaceuticals Co., Ltd. 52-week low Share Price is USD 3.93 on July 30, 2024, which is -4.59% below the current Share Price.
Chengdu Easton Biopharmaceuticals Co., Ltd. average Share Price for the last 52 weeks is USD 4.89.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

Shanghai Stock Exchange: 688513.SS

Chengdu Easton Biopharmaceuticals Co., Ltd.

CEO	Mr. Mingxu Yuan
IPO Date	Sept. 2, 2020
Location	China
Headquarters	No.8, Xiyuan Avenue
Employees	1,400
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry , and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.

Key trends

Past 5 years